News

24. April 2015

Nature Communications Publications on the First X-ray Crystal Structures of Spiegelmers Bound to Protein Targets
Anti-CCL2 and anti-C5a Spiegelmers Revealed in Complex with Their Targets

31. März 2015

Probiodrug reports full year 2014 financial results

20. März 2015

Probiodrug to present data on its Anti-pGlu-3 Abeta monoclonal Antibody at the 12th International Conference on Alzheimer's and Parkinson's Diseases (AD/PDTM 2015), Nice 

9. März 2015

Probiodrug announces enrolment of first patient in Phase 2 Study of novel Treatment for Alzheimer's disease

3. März 2015

Data on Glutaminyl Cyclases (QCs) in its relation to Alzheimer's Disease (AD) published in Acta Neuropathologica

25. Februar 2015

Probiodrug to present at European Life Sciences Conferences

16. Februar 2015

Roche übernimmt Signature Diagnostics zur Verstärkung der translationalen Forschung für Diagnostika basierend auf Sequenzierungsmethoden der nächsten Generation (NGS)

9. Februar 2015

Probiodrug to Present at Drug Discovery USA 2015

4. Februar 2015

Probiodrug to present at 17th Annual BIO CEO & Investor Conference, New York City

Seiten